NCT05670262 The Roles of Human Microbiome and Vitamin D in the Development of Childhood Allergic Diseases
| NCT ID | NCT05670262 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | Pediatric |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2022-08-04 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2022-08-04 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A birth cohort study to evaluate the role of human microbiome and vitamin D in the development of allergic diseases in young child before one year of age.
Eligibility Criteria
Inclusion Criteria: * All term newborn babies who are born in China Medical University Hospital. The term baby defines the maternal gestational age between 37 0/7 weeks to 41 6/7 weeks. Exclusion Criteria: * The exclusion criteria are prematurity newborn, congenital anomalies and cardiopulmonary failure need for resuscitation immediately after birth.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05670262 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 1 Year, studying Pediatric. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05670262 currently recruiting?
Yes, NCT05670262 is actively recruiting participants. Contact the research team at aim.cmuh@gmail.com for enrollment information.
Where is the NCT05670262 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT05670262 clinical trial?
NCT05670262 is sponsored by China Medical University Hospital. The trial plans to enroll 6,000 participants.